Cyclica Revenue and Competitors

Toronto, ON CAN

Location

$23.8M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Cyclica's estimated annual revenue is currently $852.5k per year.(i)
  • Cyclica's estimated revenue per employee is $77,500
  • Cyclica's total funding is $23.8M.

Employee Data

  • Cyclica has 11 Employees.(i)
  • Cyclica grew their employee count by -83% last year.

Cyclica's People

NameTitleEmail/Phone
1
Co-Founder, President and CEOReveal Email/Phone
2
General Counsel and Corporate SecretaryReveal Email/Phone
3
VP Corporate DevelopmentReveal Email/Phone
4
VP, Drug DiscoveryReveal Email/Phone
5
Chief Financial OfficerReveal Email/Phone
6
Director, Machine LearningReveal Email/Phone
7
Associate Director LegalReveal Email/Phone
8
Chief Science Officer, Head Drug DiscoveryReveal Email/Phone
9
Manager, People and OperationsReveal Email/Phone
10
Software DeveloperReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.7M9-72%$39.4MN/A
#2
$0.9M11-83%$23.8MN/A
#3
$87.6M5656%N/AN/A
#4
$2.8M1813%N/AN/A
#5
$7.8M50-68%N/AN/A
#6
$13.5M8730%N/AN/A
#7
$17.8M115-6%N/AN/A
#8
$0.9M11-39%N/AN/A
#9
$13.6M88-20%$86MN/A
#10
$20M129-12%N/AN/A
Add Company

What Is Cyclica?

Cyclica is decentralizing the discovery of better medicines by combining its deep roots in Artificial Intelligence (AI) and protein biophysics with an innovative business model

keywords:N/A

$23.8M

Total Funding

11

Number of Employees

$852.5k

Revenue (est)

-83%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Cyclica News

2022-04-06 - Cyclica, Arctoris partnership focuses on Alzheimer's disease

Cyclica and Arctoris have expanded their partnership to progress drug discovery programs for novel neurodegenerative targets, focusing on...

2022-03-22 - Cyclica and Arctoris to Expand Partnership to Advance Drug ...

TORONTO & OXFORD, England--(BUSINESS WIRE)--Cyclica Inc. (“Cyclica”), a neo-biotech with the vision to advance the most robust and...

2020-06-24 - Cyclica banks $17M to decentralize drug discovery, speed drug development W h i t e p a p e r Vital Precision for Cost Reduction, QA, and Regulatory Compliance

Cyclica started out licensing its drug-design software to biopharma companies, but it quickly realized that route was “simply not inspiring.” Rather than zeroing in on a particular disease area like a traditional biotech or teaming up with a Big Pharma like other drug discovery outfits, the Toro ...

2020-06-24 - Cyclica secures $23 million as it looks to create “the future biotech pipeline”

Biotech startup Cyclica has raised $23 million CAD in Series B financing. The company offers a drug discovery platform that leverages artificial intelligence and computational biophysics. The equity round, which closed around the end of April, was led by Columbus, Ohio-based Drive Capital. Ital ...

2020-06-24 - Cyclica Raises CAD$23M in Series B Financing

Cyclica, a Toronto, Canada-based neo biotech company, closed a CAD$23M Series B round of financing. The round was led by Drive Capital with participation from Chiesi Farmaceutici, GreenSky Capital, and members of Cyclica’s management team. The company intends to use the funds for continued inn ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$0.7M11-58%$16.9M
#2
$2.2M110%N/A
#3
$0.7M110%$34.4M
#4
$1.4M11-45%N/A
#5
$1.4M110%N/A